Dr. Carlo Aschele - E.O. Ospedali Galliera, Italy - speaking at the ASCO press conference: Adding oxaliplatin (Eloxatin) to standard treatment in patients with locally advanced rectal cancer does not improve tumour response. A preliminary analysis, however, suggests the treatment may reduce distant metastases.
Link to this comment:
All Comments (0)